| 臺大學術典藏 |
2019-12-04T08:43:43Z |
Paraneoplastic pemphigus: A retrospective case series in a referral center in northern Taiwan
|
Cho Y.-T.;Kao J.-T.;Chen H.-J.;Wang L.-F.;Chia-Yu Chu; Cho Y.-T.; Kao J.-T.; Chen H.-J.; Wang L.-F.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:43Z |
First-line combination therapy with rituximab and corticosteroids is effective and safe for pemphigus
|
Cho Y.-T.;Lee F.-Y.;Chia-Yu Chu;Wang L.-F.; Cho Y.-T.; Lee F.-Y.; CHIA-YU CHU; Wang L.-F. |
| 臺大學術典藏 |
2019-12-04T08:43:42Z |
Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features
|
Cho Y.-T.;Lin J.-W.;Chen Y.-C.;Chang C.-Y.;Hsiao C.-H.;Chung W.-H.;Chia-Yu Chu; Cho Y.-T.; Lin J.-W.; Chen Y.-C.; Chang C.-Y.; Hsiao C.-H.; Chung W.-H.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:41Z |
Liver injury in patients with DRESS: A clinical study of 72 cases
|
Lin I.-C.;Yang H.-C.;Strong C.;Yang C.-W.;Cho Y.-T.;Chen K.-L.;Chia-Yu Chu; Lin I.-C.; Yang H.-C.; Strong C.; Yang C.-W.; Cho Y.-T.; Chen K.-L.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:40Z |
First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid
|
Wang L.F.; Cho Y.T.; CHIA-YU CHU; Cho Y.T.;Chia-Yu Chu;Wang L.F. |
| 臺大學術典藏 |
2019-12-04T08:43:40Z |
Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions - A prospective comparative study
|
Chen Y.-C.;Chiang H.-H.;Cho Y.-T.;Chang C.-Y.;Chen K.-L.;Yang C.-W.;Lee Y.-H.;Chia-Yu Chu; Chen Y.-C.; Chiang H.-H.; Cho Y.-T.; Chang C.-Y.; Chen K.-L.; Yang C.-W.; Lee Y.-H.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:38Z |
Long-term sequelae of stevens-johnson syndrome/toxic epidermal necrolysis
|
Yang C.-W.;Cho Y.-T.;Chen K.-L.;Chen Y.-C.;Song H.-L.;Chia-Yu Chu; Yang C.-W.; Cho Y.-T.; Chen K.-L.; Chen Y.-C.; Song H.-L.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:37Z |
The Role of Viral Reactivation in Drug Reaction with Eosinophilia and Systemic Symptoms and Other Cutaneous Adverse Drug Reactions (cADRs)
|
Yang C.-W.;Chen Y.-C.;Cho Y.-T.;Chia-Yu Chu; Yang C.-W.; Chen Y.-C.; Cho Y.-T.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:37Z |
Comparison of skin toxic effects associated with gefitinib, erlotinib, or afatinib treatment for non-small cell lung cancer
|
Chen K.-L.;Lin C.-C.;Cho Y.-T.;Yang C.-W.;Sheen Y.-S.;Tsai H.-E.;Chia-Yu Chu; Chen K.-L.; Lin C.-C.; Cho Y.-T.; Yang C.-W.; Sheen Y.-S.; Tsai H.-E.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:34Z |
Co-existence of histopathological features is characteristic in drug reaction with eosinophilia and systemic symptoms and correlates with high grades of cutaneous abnormalities
|
Cho Y.-T.;Liau J.-Y.;Chang C.-Y.;Yang C.-W.;Chen K.-L.;Chen Y.-C.;Song H.-L.;Chia-Yu Chu; Cho Y.-T.; Liau J.-Y.; Chang C.-Y.; Yang C.-W.; Chen K.-L.; Chen Y.-C.; Song H.-L.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:33Z |
Treatments for Severe Cutaneous Adverse Reactions
|
Cho Y.-T.;Chia-Yu Chu; Cho Y.-T.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:32Z |
Drug reaction with eosinophilia and systemic symptoms (DRESS): An interplay among drugs, viruses, and immune system
|
Cho Y.-T.;Yang C.-W.;Chia-Yu Chu; Cho Y.-T.; Yang C.-W.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:31Z |
Epidemiology and comorbidities of patients with chronic urticaria in Taiwan?: A nationwide population-based study
|
Chia-Yu Chu;Cho Y.-T.;Jiang J.-H.;Lin E.I.-C.;Tang C.-H.; CHIA-YU CHU; Cho Y.-T.; Jiang J.-H.; Lin E.I.-C.; Tang C.-H. |
| 臺大學術典藏 |
2019-12-04T08:43:31Z |
Purpuric drug eruptions caused by epidermal growth factor receptor inhibitors for non–small cell lung cancer: A clinicopathologic study of 32 cases
|
Cho Y.-T.;Chen K.-L.;Sheen Y.-S.;Yang C.-W.;Liau J.-Y.;Cheng Y.-P.;Chia-Yu Chu; Cho Y.-T.; Chen K.-L.; Sheen Y.-S.; Yang C.-W.; Liau J.-Y.; Cheng Y.-P.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:30Z |
Olmutinib-induced palmoplantar keratoderma
|
Chen K.L.;Cho Y.T.;Yang C.W.;Sheen Y.S.;Liang C.W.;Lacouture M.E.;Chia-Yu Chu; Chen K.L.; Cho Y.T.; Yang C.W.; Sheen Y.S.; Liang C.W.; Lacouture M.E.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:30Z |
Efficacy of omalizumab treatment for patients with chronic idiopathic urticaria (CIU)/chronic spontaneous urticaria (CSU) in Taiwan
|
Yang C.-W.;Cho Y.-T.;Chia-Yu Chu; Yang C.-W.; Cho Y.-T.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:29Z |
Fever, eosinophilia, and abnormal liver function are early signs suggestive of DRESS: A comparative study between DRESS and MPE
|
Hsu S.-H.;Yang C.-W.;Hsieh Y.-C.;Cho Y.-T.;Liau J.-Y.;Liang C.-W.;Cheng Y.-P.;Chia-Yu Chu; Hsu S.-H.; Yang C.-W.; Hsieh Y.-C.; Cho Y.-T.; Liau J.-Y.; Liang C.-W.; Cheng Y.-P.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:28Z |
Using a novel scoring system for paronychia related to oncologic treatments (SPOT) for assessing paronychia severity and its correlation with pain index and quality of life
|
Ho P.-H.;Lin I.-C.;Yang X.;Cho Y.-T.;Chia-Yu Chu; Ho P.-H.; Lin I.-C.; Yang X.; Cho Y.-T.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:27Z |
Maintenance therapy with azathioprine prolonged duration of remission for pemphigus patients who received rituximab as first-line or add-on therapy
|
Cho Y.-T.; Huang Y.-M.; Wang L.-F.; CHIA-YU CHU; Cho Y.-T.;Huang Y.-M.;Wang L.-F.;Chia-Yu Chu |
| 臺大學術典藏 |
2019-12-04T08:43:26Z |
Patients with chronic urticaria have a higher risk of psychiatric disorders: a population-based study
|
Chia-Yu Chu;Cho Y.T.;Jiang J.H.;Chang C.C.;Liao S.C.;Tang C.H.; CHIA-YU CHU; Cho Y.T.; Jiang J.H.; Chang C.C.; Liao S.C.; Tang C.H. |
| 臺大學術典藏 |
2019-12-04T08:43:24Z |
Comment on “Abnormal erythrocyte morphology in drug reaction with eosinophilia and systemic symptoms”
|
Cho Y.-T.;Chia-Yu Chu; Cho Y.-T.; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T03:26:00Z |
Purpuric drug eruptions caused by epidermal growth factor receptor inhibitors for non–small cell lung cancer: A clinicopathologic study of 32 cases
|
Cheng Y.-P.; Chu C.-Y.; Liau J.-Y.; Yang C.-W.; YI-SHUAN SHEEN; Chen K.-L.; Cho Y.-T.; Cho Y.-T.;Chen K.-L.;Yi-Shuan Sheen;Yang C.-W.;Liau J.-Y.;Cheng Y.-P.;Chu C.-Y. |
| 臺大學術典藏 |
2019-12-04T03:25:59Z |
Olmutinib-induced palmoplantar keratoderma
|
Chen K.L.;Cho Y.T.;Yang C.W.;Yi-Shuan Sheen;Liang C.W.;Lacouture M.E.;Chu C.Y.; Chen K.L.; Cho Y.T.; Yang C.W.; YI-SHUAN SHEEN; Liang C.W.; Lacouture M.E.; Chu C.Y. |
| 國立成功大學 |
2019 |
Using a novel scoring system for paronychia related to oncologic treatments (SPOT) for assessing paronychia severity and its correlation with pain index and quality of life
|
Ho, P.-H.;Lin, I.-C.;Yang, X.;Cho, Y.-T.;Chu, Chu C.-Y. |
| 國立成功大學 |
2019 |
Moviprint: Move, explore and fabricate
|
Cho, Y.-T.;Yeh, Yeh Y.-T.;Kuo, Y.-L.;Lee, Y.-C. |
